BBA
TBRA

Baker Bros. Advisors’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Baker Bros. Advisors’s Portfolio TBRA Stock Details TBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-44,444
Closed -$2.72M – 112
2014
Q2 		$2.72M Hold
44,444
– – 0.03% 85
2014
Q1 		$5.01M Buy
+44,444
New +$3.12M 0.06% 69

Other funds holding TBRA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Baker Bros. Advisors's TBRA Position: Q3 2014 in Review

Baker Bros. Advisors sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q3 2014, closing a stake of 44,444 shares — an estimated $2.72M sold.

Baker Bros. Advisors first reported a position in TBRA in Q1 2014 and held it in 2 quarters. The position peaked at $5.01M in Q1 2014. 47 funds tracked by Wall St. Rank hold TBRA as of Q3 2014.

  • Baker Bros. Advisors reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q3 2014 after selling out during the quarter.
  • Baker Bros. Advisors sold 44,444 Tobira Therapeutics, Inc. Common Stock shares in Q3 2014, an estimated $2.72M.
  • Baker Bros. Advisors first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2014 and held it in 2 quarters.
  • Baker Bros. Advisors's Tobira Therapeutics, Inc. Common Stock position peaked at $5.01M in Q1 2014.
  • 47 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q3 2014.

Based on Baker Bros. Advisors's 13F filing for Q3 2014, filed 14 Nov 2014.